VETOQUINOL, A BEAUTIFUL HISTORY
The head office in Lure (France)It all started in 1933 in a pharmacy in the town of Lure, in north-eastern France. Joseph Frechin annexed to his dispensary an activity of manufacturing human pharmaceutical specialties under the name of Eastern Biochemical Laboratories.
He has the entrepreneur's intuition: to use the antiseptic properties of oxyquinoline to treat animals.
This remedy, called Vétoquinol, quickly proved itself and Joseph Frechin added a veterinary department to his laboratory. From 1970, to the great satisfaction of veterinarians, the catalog included more than 250 products.
VETOQUINOL, AN INTERNATIONAL DIMENSION
Since then, Vetoquinol has continued to develop and to offer innovative medicines and solutions to its customers.
Our desire for growth and internationalization has enabled us, since the 1980s, to achieve 20% of our turnover outside France.
Vetoquinol creates its first subsidiaries in the Netherlands, Ireland, Belgium. In 2004, we set up in China, then in 2009 in India with the creation of a new subsidiary, followed by another in Brazil in 2011. In 2014, thanks to the acquisition of Bioniche Animal Health, Vetoquinol is now directly present in Australia.
In 2006, the IPO enabled the Group to increase its international reputation, which has become a real asset.
Today, with a direct presence in 24 countries, in Europe, in North and South America and in Asia / Pacific, with our 2,500 collaborators and with nearly 100 distributors in 80 other countries, we have woven a world wide web which allows us to be close to our customers, all over the world.
THE WELL-BEING OF ANIMALS AND PEOPLE IS AT THE HEART OF OUR BUSINESS. ALL OUR TEAMS AROUND THE WORLD ARE WORKING TOWARDS THIS.
Thanks to our expertise, we have built a real relationship of trust with our customers and we work every day to improve this partnership. Innovative products and services that meet the real daily needs of our customers (veterinarians, breeders and pet owners), a constant concern for continuous improvement ... We do everything we can to carry out the mission that we are fixed.
PRESENCE IN FRANCE
In France, as everywhere in the world, and in close collaboration with veterinarians, Vetoquinol is exclusively dedicated to animal health.
More than 500 people put their skills, their passion and their energy at the service of our French and international customers, from production, packaging, shipping to order tracking, sales and technical support for medicines.
Historic cradle of the Vetoquinol Group, which was created there in 1933, France today represents less than 20% of the Vetoquinol Group's turnover, which places it on the French animal health market:
- in 5 ° for pets,
- in 7 ° for farm animals.
Among the strengths of the wide range of Vetoquinol products, we can cite in particular antibiotics, anti-inflammatories, hygiene products and topical products.
RESEARCH AND DEVELOPMENT
VETOQUINOL, WHERE INNOVATION IS A TEAM WORK
INNOVATION AND CREATIVITY
At Vetoquinol, more than 150 employees worldwide work to develop innovative products that meet the needs of our customers. Scientific Department, Medical Research Department, Product Projects Department… Each Vetoquinol project is built in close collaboration by multidisciplinary teams and numerous departments. They work together for better internal coherence and for the creation of synergies.
Vetoquinol researchers are exploring the pathways that lead from the active ingredient to the animal. A lot of creative work is necessary to make the treatment the most effective and the most easily administered, in other words useful and usable. In this process, teamwork is a key element of success in carrying out projects.
PHARMACEUTICAL RESEARCH, A LONG AND COMPLEX PROCESS
INNOVATION AND CREATIVITY
The development of a new veterinary drug requires time (on average from 5 to 10 years), the participation of multidisciplinary teams and a significant investment that can range from 3 to 15 million euros.
In the process of researching veterinary drugs, the galenic is a key element: it is constantly necessary to invent pharmaceutical formulas easy to use for the veterinarian, the breeder and the owner of pets. By always looking for the best dosage, the best time, the best place to administer the drug, Vetoquinol acts both for the safety of the animal and its owner, and also for the profitability of the breeder who will quickly return his animals in production without risk to the consumer.
Some examples where galenics make the difference:
- Appetizing tablets, taken spontaneously by dogs and cats,
- Long-acting injectable formulas with single administration, practical for injecting antibiotics into a herd,
- A treatment for dogs in liquid form, in daily dose, easily and precisely administered by the owners.
AMM, THE ULTIMATE OBJECTIVE OF PHARMACEUTICAL RESEARCH
To be able to market a human or veterinary drug, a Marketing Authorization (MA) must be obtained. Issued on the basis of a very complete dossier, the AMM proves that the product meets the requirements of the health authorities in terms of quality, safety and efficacy. Once the product is on the market, Vetoquinol continues to monitor the safety and efficacy of its drugs, thanks to two observatories dedicated to pharmacovigilance and epidemiosurveillance.